世界中医药
世界中醫藥
세계중의약
WORLD CHINESE MEDICINE
2013年
10期
1251-1252
,共2页
李妍伸%李和平%袁源%王建华%高福生%张彦周
李妍伸%李和平%袁源%王建華%高福生%張彥週
리연신%리화평%원원%왕건화%고복생%장언주
通心络胶囊%冠心病心绞痛%介入治疗
通心絡膠囊%冠心病心絞痛%介入治療
통심락효낭%관심병심교통%개입치료
Tongxinluo capsule%Angina pectoris of coronary heart disease%Percutaneous coronary intervention
目的:观察通心络胶囊对冠心病心绞痛患者介入治疗后的影响。方法:将我院收治的240例冠心病心绞痛患者,随机分为治疗组和对照组各120例,两组患者均给予规范西药治疗,治疗组在规范西药治疗基础上加服通心络,治疗时间6个月,观察治疗前后心绞痛疗效、心电图改善、LVEF和6min步行试验变化。结果:治疗6个月后,治疗组心绞痛疗效、心电图疗效、LVEF和6min步行试验明显优于对照组(P<0.05)。结论:冠心病心绞痛患者PCI术后规范西药治疗基础上加用通心络胶囊可获得较好的临床疗效。
目的:觀察通心絡膠囊對冠心病心絞痛患者介入治療後的影響。方法:將我院收治的240例冠心病心絞痛患者,隨機分為治療組和對照組各120例,兩組患者均給予規範西藥治療,治療組在規範西藥治療基礎上加服通心絡,治療時間6箇月,觀察治療前後心絞痛療效、心電圖改善、LVEF和6min步行試驗變化。結果:治療6箇月後,治療組心絞痛療效、心電圖療效、LVEF和6min步行試驗明顯優于對照組(P<0.05)。結論:冠心病心絞痛患者PCI術後規範西藥治療基礎上加用通心絡膠囊可穫得較好的臨床療效。
목적:관찰통심락효낭대관심병심교통환자개입치료후적영향。방법:장아원수치적240례관심병심교통환자,수궤분위치료조화대조조각120례,량조환자균급여규범서약치료,치료조재규범서약치료기출상가복통심락,치료시간6개월,관찰치료전후심교통료효、심전도개선、LVEF화6min보행시험변화。결과:치료6개월후,치료조심교통료효、심전도료효、LVEF화6min보행시험명현우우대조조(P<0.05)。결론:관심병심교통환자PCI술후규범서약치료기출상가용통심락효낭가획득교호적림상료효。
Objective:To observe the effects of Tongxinluo capsule on acute myocardial infraction patients of coronary heart disease and angina pectoris patient after PCI .Methods:240 patients with unstable angina after PCI were randomly divided into treatment group ( n=120) and control group (n=120).Two groups were given routine treatment for 6-month treatment, Tongxinluo was added to treatment group.Observation indicator are angina frequent duration time , left ejection fraction(LVEF),ECG results and 6 minute Walk test .Re-sults:After 6 months of treatment , treatment group showed significantly better improvement of all indicators than the control group ( P<0.05) .Conclusion:Tongxinluo capsule has good curative effect on angina pectoris of coronary heart disease .